Archive: 10/03/2014

Targeted drug may prolong survival of patients with cervical cancer

A new clinical study has found that erlotinib, a targeted antitumor agent, has promising potential to improve treatment for cervical cancer. Published early online in CANCER, a peer-reviewed journal of the American Cancer ...

Mar 10, 2014

Takeda and UCL to work together to tackle muscle disorders

Japanese pharmaceutical company Takeda will work with University College London (UCL) to drive research into tackling muscle disorders, in particular muscular dystrophy.

Mar 10, 2014

page 9 from 9

«
»